Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,045
datasets available to search
ShareScore release 0.9.0
Dataset results
1,045 results for “neoadjuvant chemotherapy”
Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy
ClinicalTrials.gov study NCT02679040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC
ClinicalTrials.gov study NCT04699721. IPD Sharing: YES. Countries: 1. Publications: 0.
Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer
ClinicalTrials.gov study NCT07125391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT04835597. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An AI Model Predicts the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: a Multicenter, Bidirectional Cohort Study
ClinicalTrials.gov study NCT06510127. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma.
ClinicalTrials.gov study NCT03691454. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2
ClinicalTrials.gov study NCT05754502. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
ClinicalTrials.gov study NCT07102381. IPD Sharing: YES. Countries: 1. Publications: 0.
Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
ClinicalTrials.gov study NCT06068985. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04848753. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
ClinicalTrials.gov study NCT06516445. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy in High - Risk Upper Tract Urothelial Carcinoma
ClinicalTrials.gov study NCT06927128. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT03491033. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy
ClinicalTrials.gov study NCT04582955. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy in Breast Cancer
ClinicalTrials.gov study NCT04802941. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer
ClinicalTrials.gov study NCT07178730. IPD Sharing: NO. Countries: 0. Publications: 0.
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
ClinicalTrials.gov study NCT02688023. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer
ClinicalTrials.gov study NCT05207514. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma
ClinicalTrials.gov study NCT04606108. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
ClinicalTrials.gov study NCT06611813. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.